These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

882 related articles for article (PubMed ID: 27487397)

  • 21. A diet low in fermentable oligo-, di-, monosaccharides and polyols improves abdominal and overall symptoms in persons with all subtypes of irritable bowel syndrome.
    Dean G; Chey SW; Singh P; Chey WD
    Neurogastroenterol Motil; 2024 Aug; 36(8):e14845. PubMed ID: 38887150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-FODMAP Diet for Irritable Bowel Syndrome: What We Know and What We Have Yet to Learn.
    Liu J; Chey WD; Haller E; Eswaran S
    Annu Rev Med; 2020 Jan; 71():303-314. PubMed ID: 31986083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diet low in fermentable oligosaccharides, disaccharides, monosaccharides and polyols, and quality of life in patients with irritable bowel syndrome in Colombia].
    Yepes IJ; Múnera MN; Martelo C
    Biomedica; 2018 May; 38(0):61-68. PubMed ID: 29809329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The long-term effect and adherence of a low fermentable oligosaccharides disaccharides monosaccharides and polyols (FODMAP) diet in patients with irritable bowel syndrome.
    Weynants A; Goossens L; Genetello M; De Looze D; Van Winckel M
    J Hum Nutr Diet; 2020 Apr; 33(2):159-169. PubMed ID: 31637777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beyond Irritable Bowel Syndrome: The Efficacy of the Low Fodmap Diet for Improving Symptoms in Inflammatory Bowel Diseases and Celiac Disease.
    Testa A; Imperatore N; Rispo A; Rea M; Tortora R; Nardone OM; Lucci L; Accarino G; Caporaso N; Castiglione F
    Dig Dis; 2018; 36(4):271-280. PubMed ID: 29763907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and Findings of a Blinded Randomized Reintroduction Phase for the Low FODMAP Diet in Irritable Bowel Syndrome.
    Van den Houte K; Colomier E; Routhiaux K; Mariën Z; Schol J; Van den Bergh J; Vanderstappen J; Pauwels N; Joos A; Arts J; Caenepeel P; De Clerck F; Matthys C; Meulemans A; Jones M; Vanuytsel T; Carbone F; Tack J
    Gastroenterology; 2024 Jul; 167(2):333-342. PubMed ID: 38401741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diet low in fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) in the treatment of irritable bowel syndrome: indications and design.
    Zugasti Murillo A; Estremera Arévalo F; Petrina Jáuregui E
    Endocrinol Nutr; 2016 Mar; 63(3):132-8. PubMed ID: 26830853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dietary Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols (FODMAPs) and Gastrointestinal Disease.
    Vakil N
    Nutr Clin Pract; 2018 Aug; 33(4):468-475. PubMed ID: 29870082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical effectiveness and economic costs of group versus one-to-one education for short-chain fermentable carbohydrate restriction (low FODMAP diet) in the management of irritable bowel syndrome.
    Whigham L; Joyce T; Harper G; Irving PM; Staudacher HM; Whelan K; Lomer MC
    J Hum Nutr Diet; 2015 Dec; 28(6):687-96. PubMed ID: 25871564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gastrointestinal tolerance of low FODMAP oral nutrition supplements in healthy human subjects: a randomized controlled trial.
    Erickson J; Korczak R; Wang Q; Slavin J
    Nutr J; 2017 May; 16(1):35. PubMed ID: 28545589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intestinal microbiota fingerprint in subjects with irritable bowel syndrome responders to a low FODMAP diet.
    Valdez-Palomares F; Nambo-Venegas R; Uribe-García J; Mendoza-Vargas A; Granados-Portillo O; Meraz-Cruz N; Palacios-González B
    Food Funct; 2021 Apr; 12(7):3206-3218. PubMed ID: 33877245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fermentable oligo-, di-, monosaccharides, and polyols (FODMAPs), but not gluten, elicit modest symptoms of irritable bowel syndrome: a double-blind, placebo-controlled, randomized three-way crossover trial.
    Nordin E; Brunius C; Landberg R; Hellström PM
    Am J Clin Nutr; 2022 Feb; 115(2):344-352. PubMed ID: 34617561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of FODMAPs in Patients With Irritable Bowel Syndrome.
    Mansueto P; Seidita A; D'Alcamo A; Carroccio A
    Nutr Clin Pract; 2015 Oct; 30(5):665-82. PubMed ID: 25694210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved Symptom Profiles and Minimal Inflammation in IBS-D Patients Undergoing a Long-Term Low-FODMAP Diet: A Lipidomic Perspective.
    Orlando A; Tutino V; Notarnicola M; Riezzo G; Linsalata M; Clemente C; Prospero L; Martulli M; D'Attoma B; De Nunzio V; Russo F
    Nutrients; 2020 Jun; 12(6):. PubMed ID: 32498383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A low fermentable oligo-di-mono saccharides and polyols (FODMAP) diet reduced pain and improved daily life in fibromyalgia patients.
    Marum AP; Moreira C; Saraiva F; Tomas-Carus P; Sousa-Guerreiro C
    Scand J Pain; 2016 Oct; 13():166-172. PubMed ID: 28850525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Feasibility of Low Fermentable Oligosaccharide, Disaccharide, Monosaccharide, and Polyol Diet and Its Effects on Quality of Life in an Italian Cohort.
    Cingolani A; Paduano D; Vecchiarelli V; Demelas M; Corrias PT; Casula L; Usai P
    Nutrients; 2020 Mar; 12(3):. PubMed ID: 32182648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low FODMAP diet reduces gastrointestinal symptoms in irritable bowel syndrome and clinical response could be predicted by symptom severity: A randomized crossover trial.
    Algera JP; Demir D; Törnblom H; Nybacka S; Simrén M; Störsrud S
    Clin Nutr; 2022 Dec; 41(12):2792-2800. PubMed ID: 36384081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IBS randomized study: FODMAPs alter bile acids, phenolic- and tryptophan metabolites, while gluten modifies lipids.
    Nordin E; Hellström PM; Vuong E; Ribbenstedt A; Brunius C; Landberg R
    Am J Physiol Regul Integr Comp Physiol; 2023 Sep; 325(3):R248-R259. PubMed ID: 37399002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of a low FODMAP diet on the colonic microbiome in irritable bowel syndrome: a systematic review with meta-analysis.
    So D; Loughman A; Staudacher HM
    Am J Clin Nutr; 2022 Oct; 116(4):943-952. PubMed ID: 35728042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychological and Gastrointestinal Symptoms of Patients with Irritable Bowel Syndrome Undergoing a Low-FODMAP Diet: The Role of the Intestinal Barrier.
    Prospero L; Riezzo G; Linsalata M; Orlando A; D'Attoma B; Russo F
    Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.